Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases


Hindilerden F., Yonal-Hindilerden I., Yenerel M. N. , Nalcaci M., Diz-Kucukkaya R.

TURKISH JOURNAL OF HEMATOLOGY, vol.34, no.1, pp.72-80, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 34 Issue: 1
  • Publication Date: 2017
  • Doi Number: 10.4274/tjh.2016.0086
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.72-80
  • Keywords: Immune thrombocytopenia, Rituximab, Early response, Late response, Sustained response, ANTI-CD20 MONOCLONAL-ANTIBODY, B-CELL DEPLETION, PURPURA, EFFICACY, SAFETY, SPLENECTOMY, MANAGEMENT, CHILDREN

Abstract

Objective: This paper prospectively evaluates the long-term follow-up [mean +/- standard deviation (SD) duration: 89.7 +/- 19.4 months] data of 15 patients (13 females and 2 males) with refractory symptomatic immune thrombocytopenia (ITP) treated with rituximab.